| scholarly article | Q13442814 |
| P356 | DOI | 10.2337/DIAB.35.9.999 |
| P698 | PubMed publication ID | 3743908 |
| P2093 | author name string | Brownlee M | |
| Cerami A | |||
| Vlassara H | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 999-1003 | |
| P577 | publication date | 1986-09-01 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | Trapped immunoglobulins on peripheral nerve myelin from patients with diabetes mellitus | |
| P478 | volume | 35 |
| Q37149382 | Advanced glycation end products and diabetic foot disease |
| Q36357263 | Advanced glycosylation endproducts on erythrocyte cell surface induce receptor-mediated phagocytosis by macrophages. A model for turnover of aging cells |
| Q34230667 | Diabetes mellitus may induce cardiovascular disease by decreasing neuroplasticity |
| Q37817010 | Homeostatic regulation of the endoneurial microenvironment during development, aging and in response to trauma, disease and toxic insult |
| Q33586285 | Increase in albumin, IgG, and IgM blood-nerve barrier indices in human diabetic neuropathy |
| Q36888784 | Increased permeability across the blood-nerve barrier of albumin glycated in vitro and in vivo from patients with diabetic polyneuropathy |
| Q58043494 | Kardiovaskuläre und pupilläre autonome und somatosensible Neuropathie bei chronischen Erkrankungen mit Autoimmunphänomenen |
| Q28510849 | Local regulation of fat metabolism in peripheral nerves |
| Q26852079 | Metabolic correction in the management of diabetic peripheral neuropathy: improving clinical results beyond symptom control |
| Q34804227 | Neurovascular disease, antioxidants and glycation in diabetes |
| Q42228859 | Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice |
| Q37103498 | The Significance of the Products of the Maillard (Browning) Reaction in Diabetes |
| Q28365458 | The role of glycation in the pathogenesis of diabetic polyneuropathy |
Search more.